Lymphoma and tracheoesophageal fistula: Indication for a removable esophageal stent

Dis Esophagus. 2005;18(1):57-9. doi: 10.1111/j.1442-2050.2005.00443.x.

Abstract

Mediastinal lymphoma is a rare cause of tracheoesophageal fistula (TEF). While most reports described in the literature have been related to prior or concurrent chemoradiation therapy, TEF has rarely been reported as the initial presentation of lymphoma. We report on a young woman found to have Hodgkin's disease complicated by TEF that required emergent placement of an esophageal stent. The lymphoma was successfully treated and, due to stent-related symptoms, removal was desired but not technically possible. We discuss options that may prevent this predicament in the future.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Renal Cell / complications
  • Chest Pain / etiology
  • Deglutition Disorders / etiology
  • Device Removal
  • Enteral Nutrition / methods
  • Esophageal Neoplasms / complications
  • Esophageal Neoplasms / therapy*
  • Female
  • Hodgkin Disease / complications
  • Hodgkin Disease / therapy*
  • Humans
  • Incidental Findings
  • Jejunostomy
  • Kidney Neoplasms / complications*
  • Neoplasms, Multiple Primary*
  • Nephrectomy
  • Prosthesis Implantation / adverse effects*
  • Prosthesis Implantation / instrumentation
  • Stents / adverse effects
  • Tracheoesophageal Fistula / etiology
  • Tracheoesophageal Fistula / therapy*

Substances

  • Antineoplastic Agents